Novo Holdings, the controlling shareholder of Novo Nordisk, reported a remarkable annual performance despite facing a challenging global economic landscape. The investment company, which manages the assets of the Novo
Novo Holdings, the controlling shareholder of Novo Nordisk, reported a remarkable annual performance despite facing a challenging global economic landscape. The investment company, which manages the assets of the Novo






